Paul Kelly - Dec 16, 2022 Form 4 Insider Report for RELMADA THERAPEUTICS, INC. (RLMD)

Role
Director
Signature
/s/ Paul Kelly
Stock symbol
RLMD
Transactions as of
Dec 16, 2022
Transactions value $
$0
Form type
4
Date filed
12/20/2022, 04:32 PM
Previous filing
Apr 5, 2022
Next filing
Feb 2, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RLMD Stock Option (right to buy) Award $0 +57K $0.00 57K Dec 16, 2022 Common Stock 57K $3.37 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests in 16 equal quarterly installments commencing on March 16, 2023.